InvestorsHub Logo
Followers 13
Posts 614
Boards Moderated 0
Alias Born 04/10/2013

Re: None

Friday, 02/05/2016 12:14:04 PM

Friday, February 05, 2016 12:14:04 PM

Post# of 54983
Apologize if this has already been posted. Here is an update from Chardan, FWIW. A couple of the more interesting paragraphs below...

http://www.xxiicentury.com/xxii2015/wp-content/uploads/2016/01/XXII_2016-01-20.pdf

Another major effort of management is attracting a research partner
to fund Phase III clinical trials for 22nd Century’s X-22 smoking
cessation product. The company is casting a wide net for partners
and using all aspect of its technology to interest potential partners.
For instance, funding of X-22 could give a partner preferred access to
the modified risk product. This would be valuable to multiple players
in the space.
Contract manufacturing will be an important source of revenue and
cash flow for the company over the coming quarters and we believe
22nd Century continues to make progress. There are a variety of
bids, large and small, in process and this could be a catalyst for the
shares in the near term.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News